ELECTROPHILIC FLUORINATION OF 6-METHYL- AND 1,3,6-TRIMETHYLURACILS
1007
Aspects to Clinical Applications, London: Imperial
College, 2012.
–116.93 d.m (J = 272.4 Hz), –129.79 d (J = 272.4 Hz).
Mass spectrum: m/z 208.0652 [M]+. C7H10F2N2O3. Cal-
culated: M 208.0654.
3. Schuman, P.D., Tarrant, P., Warner, D.A., and West-
moreland, G., US Patent no. 3954758, 1976; Chem.
Abstr., 1976, vol. 85, no. P123964e.
4. Cech, D., Herrmann, G., and Holy, A., Nucleic Acids
Res., 1977, vol. 4, p. 3259.
5. Kobayashi, Y., Kumadaki, I., and Nakazato, A., Tetra-
hedron Lett., 1980, vol. 21, p. 4605.
6. Haas, A. and Kortmann, D., Chem. Ber., 1981, vol. 114,
(5R,6R)- and (5R,6S)-5-Fluoro-6-hydroxy-6-
methylhexahydropyrimidine-2,4-diones 7a and 7b
and (5R,6R)- and (5R,6S)-5-fluoro-6-hydroxy-1,3,6-
trimethylhexahydropyrimidine-2,4-diones 8a and
8b. 1H NMR spectrum (DMSO-d6), δ, ppm, 7a: 1.36 d
(CH3, J = 2.2 Hz), 4.49 d (5-H, J = 48.1 Hz), 10.55 s
(NH), 10.76 s (NH); 7b: 1.40 s (CH3), 5.18 d (5-H, J =
47.1 Hz), 8.31 s (NH), 10.34 s (NH); 8a: 1.29 d (CH3,
J = 2.1 Hz), 2.84 s (NMe), 2.97 s (NMe), 4.98 d (5-H,
J = 47.7 Hz); 8b: 1.51 s (CH3), 2.89 s (NMe), 2.96 s
p. 1176.
7. Diksic, M., Farrokhzad, S., and Colebrook, L.D., Can.
J. Chem., 1986, vol. 64, p. 424.
8. Visser, G.W.M., Boele, S., Van Halteren, B.W.,
Knops, G.H.J.N., Herscheid, J.D.M., Brinkman, G.A.,
and Hoekstra, A., J. Org. Chem., 1986, vol. 51, p. 1466.
9. Barton, D.H.R., Bubb, W.A., Hesse, R.H., and
Pechet, M.M., J. Chem. Soc., Perkin Trans. 1, 1974,
p. 2095.
19
(NMe), 5.26 d (5-H, J = 46.5 Hz). F NMR spectrum
(DMSO-d6), δF, ppm: 7a: –192.4 d.d (J = 48.3,
2.5 Hz); 7b: –213.7 d.t (J = 47.2, 2.7 Hz); 8a:
–202.98 d (J = 47.8 Hz); 8b: ‒208.60 d (J = 46.6 Hz).
Kinetic study of the reaction of 6-methyluracil
(1) with F-TEDA-BF4. Preliminarily prepared solu-
tions of compound 1 (c = 0.079 M) and F-TEDA-BF4
(c = 0.0159 M) were kept for 60 min at 40°C and were
then mixed together. The progress of the reaction was
monitored by the concentration of F-TEDA-BF4
(samples were withdrawn at definite time intervals),
which was determined by iodometric titration [24].
The kinetic study of the fluorination of compounds 2
and 3 was performed in a similar way.
10. Barton, D.H.R., Hesse, R.H., Toh, H.T., and
Pechet, M.M., J. Org. Chem., 1972, vol. 37, p. 329.
11. Yurasova, T.I., Zh. Obshch. Khim., 1974, vol. 44, p. 956.
12. Stavber, S. and Zupan, M., Tetrahedron, 1990, vol. 46,
p. 3093.
13. Borodkin, G.I. and Shubin, V.G., Russ. Chem. Rev.,
2010, vol. 79, no. 4, p. 259.
14. Hiyama, T., Organofluorine Compounds: Chemistry and
Applications, Berlin: Springer, 2000.
15. Kirsch, P., Modern Fluoroorganic Chemistry. Synthesis,
Reactivity, Applications, Weinheim: Wiley-VCH, 2004.
16. Uneyama, K., Organofluorine Chemistry, Oxford:
Blackwell, 2006.
17. Liang, T., Neumann, C.N., and Ritter, T., Angew. Chem.,
Int. Ed., 2013, vol. 52, p. 8214.
Competing fluorination of compounds 1 and 2
with F-TEDA-BF4. Compounds 1 and 2, 0.13 mmol
each, were dissolved in 4 mL of water, 0.032 mmol of
F-TEDA-BF4 was added, and the mixture was kept for
3 h at 70°C. The solvent was removed by purging with
a stream of air, the residue was dissolved in DMSO-d6,
18. Singh, R.P. and Shreeve, J.M., Acc. Chem. Res., 2004,
1
19
and the H and F NMR spectra were recorded. The
ratio of the fluorination products was determined from
the 1H and 19F NMR signal intensities.
vol. 37, p. 31.
19. Lal, G.S., Pastore, W., and Pesaresi, R., J. Org. Chem.,
1995, vol. 60, p. 7340.
20. Rangwala, H.S., Giraldes, J.W., and Gurvich, V.J.,
This study was performed under financial support
by the Chemistry and Materials Science Department,
Russian Academy of Sciences (project no. 5.1.4).
J. Labelled Compd. Radiopharm., 2011, vol. 54, p. 340.
21. Jang, Y.H., Sowers, L.C., Çağin, T., and Goddard, W.A.
III, J. Phys. Chem. A, 2001, vol. 105, p. 274.
22. Organic Syntheses, Blatt, A.H., Ed., New York: Wiley,
REFERENCES
1943, collect. vol. 2, p. 422.
1. Mashkovskii, M.D., Lekarstvennye sredstva (Medicines),
23. Scannell, M.P., Prakash, G., and Falvey, D.E., J. Phys.
Chem. A, 1997, vol. 101, p. 4332.
Moscow: Novaya Volna, 2010, 16th ed.
2. Gouverneur, V. and Müller, K., Fluorine in Pharma-
24. Iskra, J., Zupan, M., and Stavber, S., Org. Biomol.
Chem., 2003, vol. 1, p. 1528.
ceutical and Medicinal Chemistry. From Biophysical
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 51 No. 7 2015